Simple Summary Cholangiocarcinoma (CCA) is a highly lethal neoplasia, which incidence
has steadily increased in the last years. Although surgical resection remains the cornerstone …

Purpose Intrahepatic cholangiocarcinoma (ICC) has a poor prognosis, when unresectable;
therefore, intra-arterial therapies (IAT) such as trans-arterial chemoembolization (TACE) and …

Intrahepatic cholangiocarcinoma (iCCA) develops inside the liver, between bile ductules
and the second-order bile ducts. It is the second most frequent primary liver cancer after …

Purpose To address the lack of prospective data on the real-life clinical application of trans-
arterial radioembolization (TARE) in Europe, the Cardiovascular and Interventional …

Simple Summary Intrahepatic cholangiocarcinoma is an aggressive primary liver cancer
originating in the intrahepatic bile ducts. While surgical resection is the only curative …

Background Y90 transarterial radioembolization (Y90-RE) may improve clinical outcomes of
unresectable intrahepatic cholangiocarcinoma (ICC); however, the optimal timing for Y90 …

Intrahepatic cholangiocarcinoma is the second most frequent primary liver cancer after
hepatocellular carcinoma. According to International Classification of Diseases-11 (ICD-11) …

Purpose To report outcomes of yttrium-90 (90 Y) radioembolization in patients with
unresectable intrahepatic cholangiocarcinoma (ICC). Materials and Methods Retrospective …

Purpose To investigate the overall efficacy and survival profile of yttrium-90 (90 Y)
radioembolization for unresectable intrahepatic cholangiocarcinoma (ICC). Materials and …

Purpose Unresectable intrahepatic cholangiocarcinoma (ICC) signifies a poor prognosis
with limited treatment options beyond systemic chemotherapy. This study's purpose was to …